Robeco Institutional Asset Management B.V. trimmed its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 23.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 12,698 shares of the company’s stock after selling 3,862 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in AmerisourceBergen were worth $1,171,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Elmwood Wealth Management Inc. lifted its position in shares of AmerisourceBergen by 8.9% during the third quarter. Elmwood Wealth Management Inc. now owns 7,533 shares of the company’s stock worth $695,000 after acquiring an additional 618 shares in the last quarter. Parsons Capital Management Inc. RI lifted its position in shares of AmerisourceBergen by 5.7% during the second quarter. Parsons Capital Management Inc. RI now owns 11,609 shares of the company’s stock worth $990,000 after acquiring an additional 621 shares in the last quarter. Donald L. Hagan LLC lifted its position in shares of AmerisourceBergen by 3.9% during the second quarter. Donald L. Hagan LLC now owns 16,681 shares of the company’s stock worth $1,422,000 after acquiring an additional 622 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its position in shares of AmerisourceBergen by 9.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 7,520 shares of the company’s stock worth $641,000 after acquiring an additional 660 shares in the last quarter. Finally, Lincoln Capital Corp lifted its position in shares of AmerisourceBergen by 4.6% during the third quarter. Lincoln Capital Corp now owns 15,174 shares of the company’s stock worth $1,399,000 after acquiring an additional 670 shares in the last quarter. 66.19% of the stock is owned by institutional investors and hedge funds.
In other AmerisourceBergen news, CEO Steven H. Collis sold 21,350 shares of the firm’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $88.33, for a total transaction of $1,885,845.50. Following the sale, the chief executive officer now owns 287,925 shares in the company, valued at $25,432,415.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Kathy H. Gaddes sold 2,652 shares of the firm’s stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $87.71, for a total value of $232,606.92. Following the sale, the insider now owns 3,891 shares in the company, valued at approximately $341,279.61. The disclosure for this sale can be found here. Insiders sold 92,928 shares of company stock worth $8,332,406 in the last quarter. 27.30% of the stock is currently owned by company insiders.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings data on Tuesday, November 6th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.44 by $0.01. AmerisourceBergen had a return on equity of 48.65% and a net margin of 0.69%. The company had revenue of $43.30 billion for the quarter, compared to the consensus estimate of $43.27 billion. During the same quarter last year, the business posted $1.33 earnings per share. The firm’s revenue was up 10.7% compared to the same quarter last year. On average, analysts predict that AmerisourceBergen Corp. will post 6.48 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 3rd. Investors of record on Monday, November 19th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.90%. This is an increase from AmerisourceBergen’s previous quarterly dividend of $0.38. AmerisourceBergen’s dividend payout ratio (DPR) is 25.85%.
Several equities research analysts have issued reports on the company. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Wednesday, October 3rd. Mizuho restated a “neutral” rating on shares of AmerisourceBergen in a research report on Wednesday, September 19th. ValuEngine upgraded AmerisourceBergen from a “sell” rating to a “hold” rating in a research report on Wednesday, September 19th. Finally, Robert W. Baird reiterated a “neutral” rating and issued a $94.00 price objective on shares of AmerisourceBergen in a research report on Friday, July 20th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $101.80.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Recommended Story: Bond
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.